Biotech businesses face fall-out from rows over modified soya, maize

The biotechnology industry is witnessing a fragmentation of policy towards genetically modified (GM) products across Europe in the wake of last year's clumsy effort by Monsanto to push GM soya onto the European market and the politically controversial EC decision to authorise marketing of Ciba-Geigy's GM maize. In February, Luxembourg joined Austria in banning imports of Ciba's maize, while France - which had supported Ciba's original application - banned commercial planting of the product and announced that all foods containing genetically modified organisms (GMOs) must be labelled. Italy has also banned planting of the maize. Interim labelling guidelines are being drafted by the European Commission in a bid to maintain some consistency across the EC.

Sign in to continue

Sign in

Trouble signing in?

Reset password: Click here


Call: 020 8267 8120

Take a 30-day trial

  • Join ENDS Report now and pay nothing for your first 30-days.



Prices on request

  • Full access to for 12 months
  • Monthly print issues
  • Clear and accessible guidance on relevant legislation
  • Integration with ENDS Compliance Manager helping you plan ahead and ensure compliance for your organisation
  • Individual or bespoke multi-user packages available

See all benefits

Need to activate your subscription?
Already a subscriber
If you haven't already, activate your subscription here>>
Company Domain Access
If your company or university has a corporate subscription simply register your email address here to gain access